The mechanisms behind these effects remained elusive until recent findings showed that VPA is a potent HDAC inhibitor and that induced differentiation of carcinoma and leukaemic cells could be associated to this activity (Gottlicher et al, 2001). The gene discussed is HDAC9; the disease is carcinoma.